Skip to content

The Blood-Belly Barrier

The Blood-Belly Barrier - Triple B

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41847
Enrollment
100
Registered
2015-05-26
Start date
2015-06-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epithelial ovarian cancer Epithelial ovarian carcinoma

Interventions

During the planned surgery (regular treatment) a maximum of four samples of peritoneum (4mm2 each) will be collected. Two peritoneal samples will contain tumormaterial and two samples of peritoneum

Sponsors

Antoni van Leeuwenhoek Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with serous ovarian cancer, FIGO stage III or IV, undergoing cytoreductive surgery or, 2. Patients undergoing abdominal surgery for a benign ovarian mass (control group)

Exclusion criteria

Exclusion criteria: Patients deprived from ability to decide for participation on her own During surgery, it appears, collection of samples is associated with additional health risk

Design outcomes

Primary

MeasureTime frame
1. Structural investigation of the peritoneum by histology and immunostaining of peritoneal components in EOC. 2. Investigation of the peritoneal micro-environment in EOC, by measurement of the quantity and characteristics of MPs and exosomes, excreted by mesothelial cells, and by measurement of cytokines with anti-angiogenic or proliferation inhibiting functions.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)